Integrated algorithm combining plasma biomarkers and cognitive assessments accurately predicts brain β-amyloid pathology

2020 Alzheimer’s disease facts and figures. Alzheimers Dement, https://doi.org/10.1002/alz.12068 (2020).

Swanson, C. J. et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Abeta protofibril antibody. Alzheimers Res. Ther. 13, 80 (2021).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Mintun, M. A. et al. Donanemab in Early Alzheimer’s Disease. N. Engl. J. Med. 384, 1691–1704 (2021).

Article 
CAS 
PubMed 

Google Scholar 

Blennow, K., Mattsson, N., Scholl, M., Hansson, O. & Zetterberg, H. Amyloid biomarkers in Alzheimer’s disease. Trends. Pharmacol. Sci. 36, 297–309 (2015).

Article 
CAS 
PubMed 

Google Scholar 

Teunissen, C. E. et al….